The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway

Previous
Previous

DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice

Next
Next

Tlr7 drives sex differences in age- and Alzheimer’s disease–related demyelination